TuHURA Biosciences, Inc. (HURA) vs Unicycive Therapeutics, Inc. (UNCY)

TuHURA Biosciences, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and Unicycive Therapeutics, Inc. are of similar size ($134.0M and $133.8M). Across the 10 metrics below, Unicycive Therapeutics, Inc. leads on 8 and TuHURA Biosciences, Inc. on 2.

Valuation

Metric HURA UNCY Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 7.37 2.38 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (25.71%) (37.15%) (28.84%)
Free cash flow yield (22.29%) (21.97%) (23.03%)

Profitability

Metric HURA UNCY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.84%) (101.07%) (57.72%)
Return on assets (92.31%) (69.05%) (49.22%)
Return on invested capital (74.20%) 0.00% 0.00%

Growth

Metric HURA UNCY Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 47.93% 70.18% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HURA UNCY Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 0.18 3.81 4.73
Net debt to EBITDA 0.12 1.43 0.96

Dividend

Metric HURA UNCY Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HURA UNCY Biotechnology median
Market cap 133.83m 133.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack